What the “No Time to Die” Box Office Means for Movie Theaters Recovery


  • “No Time to Die” grossed US $ 56 million over the weekend, below expectations.
  • There could be issues for potential blockbusters in an overcrowded market that is still recovering from the pandemic.
  • Still, the film is performing well internationally and has earned over $ 300 million worldwide.

After a year and a half late, the James Bond film “No Time to Die” landed in North American theaters this weekend. But the box office didn’t have the kind of oomph you’d expect from star Daniel Craig’s latest outing as a character.

The film made $ 56 million over the weekend, below some projections and less than what the previous three Bond films made when they debuted in the United States.

Here’s what all of the previous Craig’s Bond entries earned on their first weekends in the US:

  • “Casino Royale” (2006) – $ 40 million
  • “Quantum of Solace” (2008) – $ 67 million
  • “Skyfall” (2012) – $ 88 million
  • “Specter” (2015) – $ 70 million

Expectations were high for “No Time to Die”, which cost $ 250 million to produce, especially after the recent success of “Shang-Chi and the Legend of the Ten Rings” and “Venom: Let There Be Carnage”, two theatrical exclusives which the audience suggested was ready to return to theaters.

Box Office Pro predicted the film would open with $ 84 million over the weekend, while Sam Mendelsohn wrote for Box Office Mojo that “Specter” numbers were possible for the film.

‘No Time to Die’ performance can’t help but feel like a disappointment after follow-up skyrocketed in the days leading up to release, with some indications pointing to a start north of $ 100 million Chris Eggertsen wrote for Box Office Pro on Sunday. “It was certainly a major long shot, although the oversized opening of ‘Let There Be Carnage’ raised hopes of a nine-figure opening.”

Instead, “No Time to Die” suggests turmoil for potential blockbusters in a crowded market still recovering from the pandemic. Paramount apparently expected this by moving “Top Gun: Maverick” from November to May 2022.

Still to come in October is “Halloween Kills” in theaters and on Peacock this weekend, along with “The Last Duel” by Ridley Scott; and “Dune” in cinemas and on

October 22. Marvel’s “Eternals” opens on November 5 and will have little competition until “Ghostbusters: Afterlife” on November 19. Then November 24 will see the release of Disney’s “Encanto” and “Resident Evil: Welcome to Raccoon City”.

But even if movies struggle at the box office, showing them exclusively in theaters, rather than delaying them again, is what theater owners want studios to do.

“It’s a process of going back to the same kind of numbers from 2019,” John Fithian, CEO of the National Association of Theater Owners, told Insider in an interview in August. “In order to jumpstart the growth of the industry and keep theaters open, you need to take it step by step.”

It’s not all bad news for “No Time to Die”. It has attracted moviegoers aged 35 and over (57% of its audience), who “took a long time to return to the movies” during the pandemic, Hollywood consultant David A. Gross said.

“If anything has kept the film from outperforming this weekend, it’s the younger bands, which are less committed to the show,” Gross said.

It is also performing well internationally and has already grossed $ 313 million globally, including its North American total. China, the world’s largest theatrical market, is yet to arrive later this month. The Bond series isn’t a staple in the country, but “Specter” made $ 83 million there, a better franchise.

Still, reaching the heights of “Skyfall” and “Specter” – which grossed $ 1.1 billion and $ 880 million respectively worldwide – seems out of the question. And the film will likely end its theatrical release with a disappointing figure given its high costs. Puck News’ Matthew Belloni estimated the combined costs of production and advertising to be nearly $ 500 million in a report released Thursday.


Leave A Reply